Glycoxidation of biological macromolecules: A critical approach to halt the menace of glycation
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Glycation is the result of covalent bonding of a free amino group of biological macromolecules with a reducing sugar, which results in the formation of a Schiff base that undergoes rearrangement, dehydration and cyclization to form a more stable Amadori product. The final products of nonenzymatic glycation of biomacromolecules like DNA, proteins and lipids are known as advanced glycation end products (AGEs). AGEs may be generated rapidly or over long times stimulated by distinct triggering mechanisms, thereby accounting for their roles in multiple settings and disease states. Both Schiff base and Amadori glycation products generate free radicals resulting in decline of antioxidant defense mechanisms and can damage cellular organelles and enzymes. This critical review primarily focuses on the mechanistic insight of glycation and the most probable route for the formation of glycation products and their therapeutic interventions. Furthermore, the prevention of glycation reaction using therapeutic drugs such as metformin, pyridoxamine and aminoguanidine (AG) are discussed with special emphasis on the novel concept of the bioconjugation of these drugs like, AG with gold nanoparticles (GNPs). At or above 10 mM concentration, AG is found to be toxic and therefore has serious health concerns, and the study warrants doing this novel bioconjugation of AG with GNPs. This approach might increase the efficacy of the AG at a reduced concentration with low or no toxicity. Using the concept of synthesis of GNPs with abovementioned drugs, it is assumed that toxicity of various drugs which are used at high doses can be minimized more effectively.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Advanced glycation end-products: A review
Singh, R., Barden, A., Mori, T., & Beilin, L. (2001) · Diabetologia · doi:10.1007/s001250051591 · Cited by 2,597
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
Kratz, F. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.010 · Cited by 2,151 · cited 1×
“The conjugation was carried out either by simple physical adsorption of the drugs onto GNPs or via the use of alkanethiol linkers (Kratz 2008).”
MethodReactive oxygen species: from health to disease
Brieger, K., Schiavone, S., Miller Jr., F. J., & Krause, K.-H. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13659 · Cited by 1,133
Hammes, H.-P., Du, X., Edelstein, D., Taguchi, T., Matsumura, T., Ju, Q., Lin, J., Bierhaus, A., Nawroth, P., Hannak, D., et al. (2003) · Nature Medicine · doi:10.1038/nm834 · Cited by 785 · cited 1×
“Experimental animal model studies have shown that benfotiamine can reduce diabetic complications like nephropathy and retinopathy (Hammes et al. 2003).”
BackgroundThe glycation of albumin: Structural and functional impacts
Rondeau, P., & Bourdon, E. (2011) · Biochimie · doi:10.1016/j.biochi.2010.12.003 · Cited by 433 · cited 1×
“Glycation of albumin decreases the antioxidant activity and binding capacity (Rondeau and Bourdon 2011).”
BackgroundAGE restriction in diabetes mellitus: a paradigm shift
Vlassara, H., & Striker, G. E. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.74 · Cited by 277 · cited 1×
“Low-AGE diets have been suggested as a possible future therapeutic option for healthy individuals at risk for the development of type 1 or type 2 diabetes (Vlassara and Striker 2011).”
BackgroundGlucose, Advanced Glycation End Products, and Diabetes Complications: What Is New and What Works
Peppa, M., Uribarri, J., & Vlassara, H. (2003) · Clinical Diabetes · doi:10.2337/diaclin.21.4.186 · Cited by 234 · cited 1×
“AGEs are direct pathogenic and accumulate in the plasma, serum and tissues of patients in different diseases, e.g. diabetes, end stage renal disease, cardiovascular, aging and arthritis (Peppa et al. 2003).”
BackgroundFaist, V., & Erbersdobler, H. F. (2001) · Annals of Nutrition and Metabolism · doi:10.1159/000046699 · Cited by 192 · cited 2×
“Kinetic studies have demonstrated that 10–30% of dietary AGEs consumed are intestinally absorbed (Faist and Erbersdobler 2001), with only one-third of ingested AGEs excreted in urine and feces.”
BackgroundTahara, N., Yamagishi, S., Matsui, T., Takeuchi, M., Nitta, Y., Kodama, N., Mizoguchi, M., & Imaizumi, T. (2012) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00177.x · Cited by 116 · cited 1×
“More recently, AGEs have been implicated in the pathogenesis of type 2 diabetes by contributing to the development of insulin resistance and low-grade inflammation known to precede the condition (Tahara et al. 2012).”
Background
Cited by
Yacoub, R., Nugent, M., Cai, W., Nadkarni, G. N., Chaves, L. D., Abyad, S., Honan, A. M., Thomas, S. A., Zheng, W., Valiyaparambil, S. A., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0184789 · Cited by 139
Ashraf, J. M., Ahmad, S., Choi, I., Ahmad, N., Farhan, M., Tatyana, G., & Shahab, U. (2015) · IUBMB Life · doi:10.1002/iub.1450 · Cited by 106
Self-citationOxidation, glycation and glycoxidation—The vicious cycle and lung cancer
Ahmad, S., Khan, M. Y., Rafi, Z., Khan, H., Siddiqui, Z., Rehman, S., Shahab, U., Khan, M. S., Saeed, M., Alouffi, S., et al. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.10.005 · Cited by 91
“coxidation is a combinational effect of both oxidation and glycation that generates AGEs and is involved in diabetes and secondary complications associated with this metabolic disorder, including cardiovascular diseases, Alzheimer’s disease and nephropathy in addition to various forms of cancer [31].”
BackgroundSelf-citationModification of lipoprotein metabolism and function driving atherogenesis in diabetes
Luciani, L., Pedrelli, M., & Parini, P. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117545 · Cited by 72
Metadata
- Authors
- Ahmad, S., Khan, M. S., Akhter, F., Khan, M. S., Khan, A., Ashraf, J. M., Pandey, R. P., & Shahab, U.
- Venue
- Glycobiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-06-19
- Volume
- 24
- Issue
- 11
- Pages
- 979-990
- ISSN
- 0959-6658 (ISSN-L)
- 1460-2423
- OpenAlex
- W2053769775
- Cited by
- 131
- References
- 9
- FWCI
- 8.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glycoxidation of biological macromolecules: A critical approach to halt the menace of glycation. https://app.cochat.ai/papers/10.1093/glycob/cwu057
- The paper
- Ahmad, S., Khan, M. S., Akhter, F., Khan, M. S., Khan, A., Ashraf, J. M., Pandey, R. P., & Shahab, U. (2014). Glycoxidation of biological macromolecules: A critical approach to halt the menace of glycation. Glycobiology. https://doi.org/10.1093/glycob/cwu057
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.